Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.
- DOI
- 10.3389/fmed.2025.1591787
- Published
- 2025
- Container
- Frontiers in medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmed.2025.1591787,
title = {Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.},
author = {Ashraf T and Malani AK and Kumar D and Sagar RS and Raj S and Kumari P and Kumari A and Bajaj S and Basit MA and Murad M and Kumar V and Kumar A},
year = {2025},
journal = {Frontiers in medicine},
doi = {10.3389/fmed.2025.1591787},
url = {https://doi.org/10.3389/fmed.2025.1591787}
}RIS
TY - JOUR TI - Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. AU - Ashraf T AU - Malani AK AU - Kumar D AU - Sagar RS AU - Raj S AU - Kumari P AU - Kumari A AU - Bajaj S AU - Basit MA AU - Murad M AU - Kumar V AU - Kumar A PY - 2025 JO - Frontiers in medicine DO - 10.3389/fmed.2025.1591787 UR - https://doi.org/10.3389/fmed.2025.1591787 ER -
APA
T, A., AK, M., D, K., RS, S., S, R., P, K., A, K., S, B., MA, B., M, M., V, K., & A, K. (2025). Efficacy and safety of mirikizumab (LY3074828) in chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1591787
Source records
- pubmed · retrieved 2026-09-27T10:12:41.393Z